First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.

Date issued
2011Journal title
Journal Of Clinical Oncology
Type of content
Publicación de congreso
